Scientist Who Cited Drug&#39;s Risks Is Barred From FDA Panel
12623
The Food and Drug Administration has told a researcher that he cannot be part of an advisory panel that will meet early next year to review the safety of a class of drugs, COX-2 inhibitors, used to treat arthritis and pain.
85181
A medical researcher who testified at a House hearing about the safety of the popular diabetes drug, Avandia, said he received the veiled threat of a lawsuit by a high-ranking drug company executive.
140812
WASHINGTON (CBS.MW) - An advisory panel to the Food and Drug Administration late Friday declined to endorse AstraZeneca&#39;s anti-stroke drug, Exanta.
95585
Nov. 19, 2004 -- New allegations from an FDA scientist that the agency is failing at its job of ensuring the safety of the drugs it approves has many Americans thinking twice before taking their daily dose.
270368
Merck &amp; Co.&#39;s recall of the Vioxx painkiller shows why the US Food and Drug Administration needs its safety monitors to be independent of those who approve new medicines, FDA scientist David J. Graham told a Senate hearing.
104980
A local researcher&#39;s invitation to participate in a federal drug-safety board meeting was rescinded after he spoke out about his concerns regarding the safety of some arthritis drugs.
123926
An advisory panel of experts recommended unanimously yesterday that the Food and Drug Administration reject a new weight-loss drug after hearing testimony that it increases the risk of suicidal behavior.
343910
A veteran scientist at the Food and Drug Administration said yesterday he will present new, unpublished findings about heart risk associated with a number of pain drugs at a meeting to assess whether they are safe enough for patients.
67655
A prominent New York scientific laboratory suspended Nobel Prize-winning DNA authority Dr. James Watson on Thursday night over racially insensitive comments he was quoted as making in an interview earlier in the week.
44749
A scientist working at the US Food and Drug Administration accuses the agency of "profound failure" in its oversight of the recently withdrawn arthritis drug Vioxx.
761219
An increased risk of heart attack and stroke from the drug naproxen halted a major US study on Alzheimer&#39;s disease prevention.
51383
Nov. 18, 2004 - An FDA scientist says the FDA, which is charged with protecting America&#39;s prescription drug supply, is incapable of doing so.
454185
GlaxoSmithKline PLC revealed Thursday that the U.S. Food and Drug Administration has declined to grant a priority review to its experimental cancer vaccine Cervarix, adding to pressure on the drug maker after controversy surrounding its diabetes drug Avandia.
21984
A drug safety reviewer said the FDA is "incapable of protecting" the public and urged the government to review five new drugs for safety issues.
275776
The National Institutes of Health banned its scientists from working as consultants for pharmaceutical, biotechnology and similar businesses, a step officials hope will end controversy over paid consulting arrangements by some of its doctors.
242627
U.S. Food and Drug Administration  officials pressured an agency safety official to keep quiet or  water down his findings that the now-withdrawn arthritis drug  Vioxx was dangerous to the heart, a leading Senate Republican  charged on Thursday.
415259
The U.S. Food and Drug  Administration denied charges it tried to suppress a safety  official's findings that painkiller Vioxx, which was pulled  from the market last week, raised heart attack risks.